Stronger Warnings for Life-Threatening Asthma Drug

Posted on February 22, 2007 by Gerald Pugliese
Sounds like putting a band-aid on a gunshot wound, doesn’t it? The U.S. Food and Drug Administration is urging manufacturers of Xolair to put stronger labels on their medication because it runs the risk of a life-threatening allergic reaction. Amanda Gardner of HealthDay News reports:
The new alert for Xolair (omalizumab), marketed by Genentech Inc., draws attention to anaphylaxis as a potential side effect of the medication…


… The new warning discusses the possibility of patients developing anaphylaxis after any dose of Xolair, even if there was no reaction to the first dose. Also, the reaction may occur up to 24 hours after administration of the drug.
If medications make you nervous, check out DiseaseProof’s Asthma archive for posts on treating asthma with superior nutrition.
Tags:
Trackbacks (0) Links to blogs that reference this article Trackback URL
Comments (0) Read through and enter the discussion with the form at the end
Post A Comment / Question Use this form to add a comment to this entry.







Remember personal info?